| No. |
Name Length
|
Chromosome No./Scaffold Id Scaffold Length |
BLAST (vs nr) |
Gene ontology |
| 17431 |
O_BomoIG21926_complete:A_BomoIG_DN28952_c0_g1_i4
155bp |
|
|
|
| 17432 |
O_BomoIG21927_complete:A_BomoIG_DN28952_c0_g1_i4
119bp |
|
|
|
| 17433 |
O_BomoIG21928_complete:A_BomoIG_DN28952_c0_g1_i4
114bp |
|
|
|
| 17434 |
O_BomoIG21929_5prime_partial:A_BomoIG_DN28952_c0_g1_i5
130bp |
|
|
|
| 17435 |
O_BomoIG2192_complete:A_BomoIG_DN33167_c2_g1_i32
121bp |
|
|
|
| 17436 |
O_BomoIG21930_3prime_partial:A_BomoIG_DN28952_c0_g1_i5
110bp |
|
|
|
| 17437 |
O_BomoIG21931_complete:A_BomoIG_DN28952_c0_g1_i6
122bp |
|
|
|
| 17438 |
O_BomoIG21932_3prime_partial:A_BomoIG_DN28905_c0_g1_i1
542bp |
|
drebrin-like_protein_B_[Bombyx_mori] |
| GO:0001786 |
F |
phosphatidylserine binding |
| GO:0003779 |
F |
actin binding |
| GO:0005546 |
F |
phosphatidylinositol-4,5-bisphosphate binding |
| GO:0005547 |
F |
phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0005737 |
C |
cytoplasm |
| GO:0005856 |
C |
cytoskeleton |
| GO:0005884 |
C |
actin filament |
| GO:0005938 |
C |
cell cortex |
| GO:0016477 |
P |
cell migration |
| GO:0022416 |
P |
chaeta development |
| GO:0030424 |
C |
axon |
| GO:0030426 |
C |
growth cone |
| GO:0030864 |
C |
cortical actin cytoskeleton |
| GO:0031594 |
C |
neuromuscular junction |
| GO:0045887 |
P |
positive regulation of synaptic assembly at neuromuscular junction |
| GO:0051015 |
F |
actin filament binding |
| GO:0061176 |
C |
type Ib terminal bouton |
| GO:0061177 |
C |
type Is terminal bouton |
| GO:0072553 |
P |
terminal button organization |
|
| 17439 |
O_BomoIG21933_complete:A_BomoIG_DN28983_c0_g1_i1
256bp |
|
lipase_member_H-B_[Bombyx_mori] |
| GO:0005576 |
C |
extracellular region |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0016020 |
C |
membrane |
| GO:0016042 |
P |
lipid catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0052689 |
F |
carboxylic ester hydrolase activity |
|
| 17440 |
O_BomoIG21934_complete:A_BomoIG_DN28983_c0_g1_i1
107bp |
|
|
|
| 17441 |
O_BomoIG21935_complete:A_BomoIG_DN28983_c0_g1_i2
132bp |
|
lipase_member_H-B_[Bombyx_mori] |
|
| 17442 |
O_BomoIG21936_complete:A_BomoIG_DN28983_c0_g1_i2
110bp |
|
|
|
| 17443 |
O_BomoIG21937_complete:A_BomoIG_DN28983_c0_g1_i3
358bp |
|
lipase_member_H-B_[Bombyx_mori] |
| GO:0005576 |
C |
extracellular region |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0016020 |
C |
membrane |
| GO:0016042 |
P |
lipid catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0052689 |
F |
carboxylic ester hydrolase activity |
|
| 17444 |
O_BomoIG21938_complete:A_BomoIG_DN28983_c0_g1_i3
110bp |
|
|
|
| 17445 |
O_BomoIG21939_internal:A_BomoIG_DN28977_c0_g1_i2
162bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0005887 |
C |
integral component of plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0007186 |
P |
G protein-coupled receptor signaling pathway |
| GO:0007589 |
P |
body fluid secretion |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0008217 |
P |
regulation of blood pressure |
| GO:0008528 |
F |
G protein-coupled peptide receptor activity |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016525 |
P |
negative regulation of angiogenesis |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030308 |
P |
negative regulation of cell growth |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0035810 |
P |
positive regulation of urine volume |
| GO:0035815 |
P |
positive regulation of renal sodium excretion |
| GO:0042312 |
P |
blood vessel diameter maintenance |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043114 |
P |
regulation of vascular permeability |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
| GO:1903779 |
P |
regulation of cardiac conduction |
|
| 17446 |
O_BomoIG2193_complete:A_BomoIG_DN33167_c2_g1_i33
3025bp |
|
LOW_QUALITY_PROTEIN:_neurobeachin_[Bombyx_mori] |
| GO:0005737 |
C |
cytoplasm |
| GO:0007528 |
P |
neuromuscular junction development |
| GO:0007614 |
P |
short-term memory |
| GO:0008104 |
P |
protein localization |
| GO:0008355 |
P |
olfactory learning |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016319 |
P |
mushroom body development |
| GO:0042462 |
P |
eye photoreceptor cell development |
| GO:0042675 |
P |
compound eye cone cell differentiation |
| GO:0043025 |
C |
neuronal cell body |
| GO:0043204 |
C |
perikaryon |
| GO:0051018 |
F |
protein kinase A binding |
|
| 17447 |
O_BomoIG21940_5prime_partial:A_BomoIG_DN28977_c0_g1_i3
129bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
|
| 17448 |
O_BomoIG21941_complete:A_BomoIG_DN28977_c0_g1_i4
213bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0008217 |
P |
regulation of blood pressure |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
|
| 17449 |
O_BomoIG21942_3prime_partial:A_BomoIG_DN28977_c0_g1_i5
246bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0005887 |
C |
integral component of plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0007186 |
P |
G protein-coupled receptor signaling pathway |
| GO:0007589 |
P |
body fluid secretion |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0008217 |
P |
regulation of blood pressure |
| GO:0008528 |
F |
G protein-coupled peptide receptor activity |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016525 |
P |
negative regulation of angiogenesis |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030308 |
P |
negative regulation of cell growth |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0035810 |
P |
positive regulation of urine volume |
| GO:0035815 |
P |
positive regulation of renal sodium excretion |
| GO:0042312 |
P |
blood vessel diameter maintenance |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043114 |
P |
regulation of vascular permeability |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
| GO:1903779 |
P |
regulation of cardiac conduction |
|
| 17450 |
O_BomoIG21943_complete:A_BomoIG_DN28915_c0_g2_i1
298bp |
|
antimicrobial_protein_6Tox_precursor_[Bombyx_mori] |
| GO:0005178 |
F |
integrin binding |
| GO:0005515 |
F |
protein binding |
| GO:0005518 |
F |
collagen binding |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005583 |
C |
fibrillar collagen trimer |
| GO:0005615 |
C |
extracellular space |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006641 |
P |
triglyceride metabolic process |
| GO:0007155 |
P |
cell adhesion |
| GO:0007160 |
P |
cell-matrix adhesion |
| GO:0008201 |
F |
heparin binding |
| GO:0016337 |
P |
cell-cell adhesion |
| GO:0030036 |
P |
actin cytoskeleton organization |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030199 |
P |
collagen fibril organization |
| GO:0031012 |
C |
extracellular matrix |
| GO:0032963 |
P |
collagen metabolic process |
| GO:0043206 |
P |
supramolecular fiber organization |
| GO:0043506 |
P |
regulation of JUN kinase activity |
| GO:0048251 |
P |
elastic fiber assembly |
| GO:0070062 |
C |
extracellular exosome |
|
| 17451 |
O_BomoIG21944_3prime_partial:A_BomoIG_DN28915_c0_g2_i3
292bp |
|
antimicrobial_protein_6Tox_precursor_[Bombyx_mori] |
| GO:0005178 |
F |
integrin binding |
| GO:0005515 |
F |
protein binding |
| GO:0005518 |
F |
collagen binding |
| GO:0005576 |
C |
extracellular region |
| GO:0005578 |
C |
extracellular matrix |
| GO:0005583 |
C |
fibrillar collagen trimer |
| GO:0005615 |
C |
extracellular space |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006641 |
P |
triglyceride metabolic process |
| GO:0007155 |
P |
cell adhesion |
| GO:0007160 |
P |
cell-matrix adhesion |
| GO:0008201 |
F |
heparin binding |
| GO:0016337 |
P |
cell-cell adhesion |
| GO:0030036 |
P |
actin cytoskeleton organization |
| GO:0030198 |
P |
extracellular matrix organization |
| GO:0030199 |
P |
collagen fibril organization |
| GO:0031012 |
C |
extracellular matrix |
| GO:0032963 |
P |
collagen metabolic process |
| GO:0043206 |
P |
supramolecular fiber organization |
| GO:0043506 |
P |
regulation of JUN kinase activity |
| GO:0048251 |
P |
elastic fiber assembly |
| GO:0070062 |
C |
extracellular exosome |
|
| 17452 |
O_BomoIG21945_5prime_partial:A_BomoIG_DN28915_c0_g2_i3
170bp |
|
hypothetical_protein_[Rickettsia_felis] |
|
| 17453 |
O_BomoIG21946_5prime_partial:A_BomoIG_DN28945_c0_g1_i2
165bp |
|
poly(U)-binding-splicing_factor_half_pint_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0000380 |
P |
alternative mRNA splicing, via spliceosome |
| GO:0000381 |
P |
regulation of alternative mRNA splicing, via spliceosome |
| GO:0000398 |
P |
mRNA splicing, via spliceosome |
| GO:0001558 |
P |
regulation of cell growth |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003723 |
F |
RNA binding |
| GO:0003729 |
F |
mRNA binding |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0006376 |
P |
mRNA splice site selection |
| GO:0006397 |
P |
mRNA processing |
| GO:0007275 |
P |
multicellular organism development |
| GO:0007282 |
P |
cystoblast division |
| GO:0008266 |
F |
poly(U) RNA binding |
| GO:0008380 |
P |
RNA splicing |
| GO:0022008 |
P |
neurogenesis |
| GO:0030154 |
P |
cell differentiation |
| GO:0043234 |
C |
protein-containing complex |
| GO:0048477 |
P |
oogenesis |
| GO:0051726 |
P |
regulation of cell cycle |
| GO:0071011 |
C |
precatalytic spliceosome |
| GO:0071013 |
C |
catalytic step 2 spliceosome |
|
| 17454 |
O_BomoIG21947_5prime_partial:A_BomoIG_DN28945_c0_g1_i3
139bp |
|
poly(U)-binding-splicing_factor_half_pint_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0000380 |
P |
alternative mRNA splicing, via spliceosome |
| GO:0000381 |
P |
regulation of alternative mRNA splicing, via spliceosome |
| GO:0000398 |
P |
mRNA splicing, via spliceosome |
| GO:0001558 |
P |
regulation of cell growth |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003723 |
F |
RNA binding |
| GO:0003729 |
F |
mRNA binding |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0006376 |
P |
mRNA splice site selection |
| GO:0006397 |
P |
mRNA processing |
| GO:0007275 |
P |
multicellular organism development |
| GO:0007282 |
P |
cystoblast division |
| GO:0008266 |
F |
poly(U) RNA binding |
| GO:0008380 |
P |
RNA splicing |
| GO:0022008 |
P |
neurogenesis |
| GO:0030154 |
P |
cell differentiation |
| GO:0043234 |
C |
protein-containing complex |
| GO:0048477 |
P |
oogenesis |
| GO:0051726 |
P |
regulation of cell cycle |
| GO:0071011 |
C |
precatalytic spliceosome |
| GO:0071013 |
C |
catalytic step 2 spliceosome |
|
| 17455 |
O_BomoIG21948_complete:A_BomoIG_DN28918_c0_g1_i1
113bp |
|
ribosomal_protein_P2_[Bombyx_mori] |
| GO:0000036 |
F |
acyl carrier activity |
| GO:0003735 |
F |
structural constituent of ribosome |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0005737 |
C |
cytoplasm |
| GO:0005840 |
C |
ribosome |
| GO:0006414 |
P |
translational elongation |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006633 |
P |
fatty acid biosynthetic process |
| GO:0008610 |
P |
lipid biosynthetic process |
| GO:0030529 |
C |
ribonucleoprotein complex |
|
| 17456 |
O_BomoIG21949_complete:A_BomoIG_DN28918_c0_g1_i1
104bp |
|
conserved_hypothetical_protein_[Culex_quinquefasciatus] |
|
| 17457 |
O_BomoIG2194_complete:A_BomoIG_DN33167_c2_g1_i33
251bp |
|
|
|
| 17458 |
O_BomoIG21950_complete:A_BomoIG_DN28918_c0_g2_i1
113bp |
|
ribosomal_protein_P1_[Bombyx_mori] |
| GO:0002181 |
P |
cytoplasmic translation |
| GO:0003735 |
F |
structural constituent of ribosome |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0005840 |
C |
ribosome |
| GO:0006414 |
P |
translational elongation |
| GO:0022625 |
C |
cytosolic large ribosomal subunit |
| GO:0030295 |
F |
protein kinase activator activity |
| GO:0030529 |
C |
ribonucleoprotein complex |
| GO:0030687 |
C |
preribosome, large subunit precursor |
| GO:0032147 |
P |
activation of protein kinase activity |
| GO:0045860 |
P |
positive regulation of protein kinase activity |
| GO:0070180 |
F |
large ribosomal subunit rRNA binding |
|
| 17459 |
O_BomoIG21951_5prime_partial:A_BomoIG_DN28918_c0_g1_i2
187bp |
|
ribosomal_protein_P2_[Bombyx_mori] |
| GO:0000036 |
F |
acyl carrier activity |
| GO:0003735 |
F |
structural constituent of ribosome |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0005737 |
C |
cytoplasm |
| GO:0005840 |
C |
ribosome |
| GO:0006414 |
P |
translational elongation |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006633 |
P |
fatty acid biosynthetic process |
| GO:0008610 |
P |
lipid biosynthetic process |
| GO:0030529 |
C |
ribonucleoprotein complex |
|
| 17460 |
O_BomoIG21952_complete:A_BomoIG_DN28918_c0_g1_i2
104bp |
|
conserved_hypothetical_protein_[Culex_quinquefasciatus] |
|